Venus Concept Inc. (VERO)
USD 2.39
(5.75%)
USD 2.39
(5.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -28.3 Million USD | 18.83% |
| 2022 | -34.87 Million USD | -98.81% |
| 2021 | -17.54 Million USD | 56.63% |
| 2020 | -40.44 Million USD | -99.38% |
| 2019 | -20.28 Million USD | 21.69% |
| 2018 | -25.9 Million USD | -49.9% |
| 2017 | -17.28 Million USD | 8.72% |
| 2016 | -18.93 Million USD | 7.76% |
| 2015 | -20.52 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.59 Million USD | 27.89% |
| 2024 Q1 | -7.76 Million USD | -1.65% |
| 2023 Q3 | -6.76 Million USD | -17.44% |
| 2023 Q4 | -7.63 Million USD | -12.9% |
| 2023 Q2 | -5.75 Million USD | 29.39% |
| 2023 FY | -28.3 Million USD | 18.83% |
| 2023 Q1 | -8.15 Million USD | 8.25% |
| 2022 FY | -34.87 Million USD | -98.81% |
| 2022 Q4 | -8.88 Million USD | 22.21% |
| 2022 Q3 | -11.42 Million USD | -60.33% |
| 2022 Q2 | -7.12 Million USD | 4.17% |
| 2022 Q1 | -7.43 Million USD | -82.79% |
| 2021 Q2 | 1.52 Million USD | 122.32% |
| 2021 Q1 | -6.83 Million USD | 30.46% |
| 2021 FY | -17.54 Million USD | 56.63% |
| 2021 Q3 | -5.38 Million USD | -453.15% |
| 2021 Q4 | -4.06 Million USD | 24.51% |
| 2020 Q3 | -5.29 Million USD | 42.41% |
| 2020 Q2 | -9.19 Million USD | 78.91% |
| 2020 FY | -40.44 Million USD | -99.38% |
| 2020 Q4 | -9.83 Million USD | -85.68% |
| 2020 Q1 | -43.58 Million USD | -143.5% |
| 2019 Q4 | -17.89 Million USD | -117.68% |
| 2019 FY | -20.28 Million USD | 21.69% |
| 2019 Q3 | -8.22 Million USD | -16.49% |
| 2019 Q2 | -7.05 Million USD | -6.71% |
| 2019 Q1 | -6.61 Million USD | 8.76% |
| 2018 Q1 | -7.04 Million USD | -84.97% |
| 2018 Q2 | -5.17 Million USD | 26.51% |
| 2018 Q3 | -6.44 Million USD | -24.51% |
| 2018 Q4 | -7.24 Million USD | -12.53% |
| 2018 FY | -25.9 Million USD | -49.9% |
| 2017 Q1 | -4.42 Million USD | -13.84% |
| 2017 FY | -17.28 Million USD | 8.72% |
| 2017 Q2 | -4.44 Million USD | -0.47% |
| 2017 Q3 | -4.6 Million USD | -3.62% |
| 2017 Q4 | -3.8 Million USD | 17.37% |
| 2016 FY | -18.93 Million USD | 7.76% |
| 2016 Q3 | -5.32 Million USD | 0.0% |
| 2016 Q4 | -3.88 Million USD | 27.04% |
| 2015 FY | -20.52 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -97.124% |
| Cerus Corporation | -30.05 Million USD | 5.803% |
| OrthoPediatrics Corp. | -25.76 Million USD | -9.87% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -166.529% |
| Talis Biomedical Corporation | -66.81 Million USD | 57.631% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -63.674% |
| Inogen, Inc. | -109.38 Million USD | 74.12% |
| Spectral AI, Inc. | -12.98 Million USD | -118.03% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 54.77% |
| CVRx, Inc. | -43.1 Million USD | 34.322% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -702.409% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -127.784% |
| Orthofix Medical Inc. | -139.11 Million USD | 79.65% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 47.603% |
| Bioventus Inc. | -81.72 Million USD | 65.361% |
| BrainsWay Ltd. | -4.92 Million USD | -474.569% |
| Envoy Medical, Inc. | -18.37 Million USD | -54.096% |
| electroCore, Inc. | -18.8 Million USD | -50.54% |
| IceCure Medical Ltd | -15.57 Million USD | -81.748% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 41.609% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -63.939% |
| MaxCyte, Inc. | -48.29 Million USD | 41.388% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -136.791% |
| Nexalin Technology, Inc. | -5.69 Million USD | -396.972% |
| PAVmed Inc | -68.79 Million USD | 58.85% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 49.951% |
| RxSight, Inc. | -50.08 Million USD | 43.478% |
| Sight Sciences, Inc. | -57.27 Million USD | 50.573% |
| SI-BONE, Inc. | -46.93 Million USD | 39.68% |
| TELA Bio, Inc. | -44.07 Million USD | 35.771% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 47.721% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 44.954% |
| LivaNova PLC | -68.49 Million USD | 58.672% |
| 908 Devices Inc. | -42.75 Million USD | 33.793% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 83.674% |
| Nemaura Medical Inc. | -9.59 Million USD | -195.032% |
| NeuroPace, Inc. | -27.17 Million USD | -4.177% |
| LENSAR, Inc. | -12.22 Million USD | -131.491% |
| Apyx Medical Corporation | -17.25 Million USD | -64.025% |
| Cutera, Inc. | -156.23 Million USD | 81.88% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -229.021% |
| BioSig Technologies, Inc. | -28.51 Million USD | 0.712% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 67.698% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -26.12% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 125.383% |
| Axonics, Inc. | -26.05 Million USD | -8.643% |
| Outset Medical, Inc. | -169.77 Million USD | 83.325% |
| IRIDEX Corporation | -10 Million USD | -182.892% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 74.069% |
| IRadimed Corporation | 20.03 Million USD | 241.294% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -243.348% |
| INVO Bioscience, Inc. | -6.76 Million USD | -318.329% |
| Telesis Bio, Inc. | -35.15 Million USD | 19.462% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 297.551% |
| Varex Imaging Corporation | 32.1 Million USD | 188.19% |
| Quipt Home Medical Corp. | 3.91 Million USD | 822.353% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -133.322% |
| Pulmonx Corporation | -61.93 Million USD | 54.292% |
| Dynatronics Corporation | -2.27 Million USD | -1145.42% |
| Modular Medical, Inc. | -17.52 Million USD | -61.498% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -93.381% |
| Semler Scientific, Inc. | 22.25 Million USD | 227.197% |
| InMode Ltd. | 195.66 Million USD | 114.468% |
| Bruker Corporation | 436.9 Million USD | 106.48% |
| Cytosorbents Corporation | -31.2 Million USD | 9.293% |
| DexCom, Inc. | 597.7 Million USD | 104.736% |
| Align Technology, Inc. | 643.33 Million USD | 104.4% |
| Viveve Medical, Inc. | -21.55 Million USD | -31.346% |
| ZimVie Inc. | -30.93 Million USD | 8.501% |
| Movano Inc. | -29.69 Million USD | 4.651% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -1.666% |
| Nexalin Technology, Inc. | -5.69 Million USD | -396.972% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -702.409% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 87.862% |
| Profound Medical Corp. | -28.61 Million USD | 1.073% |
| Insulet Corporation | 220 Million USD | 112.868% |
| enVVeno Medical Corporation | -25.23 Million USD | -12.168% |
| Surmodics, Inc. | -5.64 Million USD | -401.488% |
| iCAD, Inc. | -7.68 Million USD | -268.175% |
| Nuwellis, Inc. | -17.63 Million USD | -60.573% |
| Biotricity, Inc. | -8.82 Million USD | -220.663% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 77.382% |
| Aethlon Medical, Inc. | -12.63 Million USD | -124.024% |
| InspireMD, Inc. | -21.14 Million USD | -33.893% |
| PAVmed Inc. | -68.79 Million USD | 58.85% |
| BIOLASE, Inc. | -17.93 Million USD | -57.825% |
| Beyond Air, Inc. | -63 Million USD | 55.069% |
| FONAR Corporation | 16.53 Million USD | 271.203% |
| AxoGen, Inc. | -21.46 Million USD | -31.903% |
| Vivani Medical, Inc. | -26.96 Million USD | -4.984% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 256.915% |
| Inari Medical, Inc. | -14.03 Million USD | -101.746% |
| UFP Technologies, Inc. | 57.66 Million USD | 149.093% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -474.499% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -348.938% |
| Tenon Medical, Inc. | -15.72 Million USD | -80.003% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -278.766% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 33.712% |
| AdaptHealth Corp. | -598.4 Million USD | 95.269% |
| Sintx Technologies, Inc. | -13.35 Million USD | -111.925% |
| NanoVibronix, Inc. | -3.43 Million USD | -723.894% |
| Quanterix Corporation | -49.7 Million USD | 43.041% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -133.322% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -7310.733% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 91.536% |
| TransMedics Group, Inc. | -28.72 Million USD | 1.455% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -19.892% |
| NeuroMetrix, Inc. | -7.15 Million USD | -295.846% |
| Hyperfine, Inc. | -48.11 Million USD | 41.164% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 56.465% |
| Biomerica, Inc. | -6.36 Million USD | -344.621% |
| Bone Biologics Corporation | -9.42 Million USD | -200.256% |
| AVITA Medical, Inc. | -40.4 Million USD | 29.932% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -174.546% |
| Silk Road Medical, Inc | -59.27 Million USD | 52.238% |